tiprankstipranks
Trending News
More News >
Abbott Laboratories (DE:ABL)
XETRA:ABL
Germany Market

Abbott Laboratories (ABL) Income Statement

Compare
13 Followers

Abbott Laboratories Income Statement

Last quarter (Q3 2025), Abbott Laboratories's total revenue was $11.37B, an increase of 6.90% from the same quarter last year. In Q3, Abbott Laboratories's net income was $1.64B. See Abbott Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 41.95B$ 40.11B$ 43.65B$ 43.08B$ 34.61B
Gross Profit
$ 21.32B$ 20.04B$ 22.32B$ 23.21B$ 17.38B
Operating Expenses
$ 14.47B$ 13.60B$ 13.96B$ 14.01B$ 12.09B
Depreciation and Amortization
$ 3.22B$ 3.24B$ 3.27B$ 3.54B$ 3.33B
EBITDA
$ 10.83B$ 10.61B$ 11.89B$ 12.16B$ 9.00B
Operating Income
$ 6.83B$ 6.43B$ 8.36B$ 9.20B$ 5.29B
Other Income/Expenses
$ 188.00M$ 229.00M$ -56.00M$ -989.00M$ -323.00M
Pretax Income
$ 7.01B$ 6.66B$ 8.31B$ 8.21B$ 4.97B
Net Income
$ 13.40B$ 5.72B$ 6.93B$ 7.07B$ 4.50B
Per Share Metrics
Basic EPS
$ 7.67$ 3.30$ 3.94$ 3.97$ 2.52
Diluted EPS
$ 7.64$ 3.27$ 3.91$ 3.94$ 2.50
Weighted Average Shares Outstanding
1.73B 1.73B 1.75B 1.77B 1.77B
Weighted Average Shares Outstanding (Diluted)
1.75B 1.75B 1.76B 1.79B 1.79B
Currency in USD

Abbott Laboratories Earnings and Revenue History